Milpitas, California-based Bigfoot Biomedical Inc. had already raised $37m in a Series B financing round in December 2017. The firm has now closed the round after raising another $18m, including funds from Abbott Laboratories Inc. as a first-time investor, along with other new and existing investors.
"We are excited to welcome Abbott to our list of investors," Jeffrey Brewer, president and CEO of Bigfoot Biomedical said. "Abbott's inclusion in our financing speaks to our two companies'...